[stock_market_widget type=”leaderboard” template=”color-background” color=”blue” assets=”AKCA” api=”yf”]
Akcea Therapeutics, Inc.
Description: Akcea Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with serious and rare diseases. It has strategic collaboration with Novartis Pharma AG and PTC Therapeutics International Limited. Akcea Therapeutics, Inc. operates as a subsidiary of Ionis Pharmaceuticals, Inc.
Industry: Biotechnology
Founded Year : 2014
Headquarter : Boston, MA, U.S.A
Website: http://www.akceatx.com
Phone: 617-207-0202
[stock_market_widget type=”leaderboard” template=”color-background” color=”blue” assets=”AIMT” api=”yf”]
Aimmune Therapeutics, Inc.
Description: Aimmune Therapeutics is a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. in May 2015.
Industry: Biotechnology
Founded Year : 2011
Headquarter : Brisbane, CA, U.S.A
Website: http://www.aimmune.com
Phone: 650-614-5220
[stock_market_widget type=”leaderboard” template=”color-background” color=”blue” assets=”DNLI” api=”yf”]
Denali Therapeutics Inc.
Description: Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. Denali Therapeutics Inc. has collaboration agreement with Takeda Pharmaceutical Company and Genentech, Inc., Sanofi, F-star Gamma Limited, F-star Biotechnologische Forschungs-Und Entwicklungsges M.B.H, F-star Biotechnology Limited, SIRION Biotech GmbH, Genzyme Corporation, Harvard University, the Michael J. Fox Foundation, and Centogene. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015.
Industry: Biotechnology
Founded Year : 2013
Headquarter : South San Francisco, CA, U.S.A
Website: http://www.denalitherapeutics.com
Phone: 650-866-8548
[stock_market_widget type=”leaderboard” template=”color-background” color=”blue” assets=”MDGL” api=”yf”]
Madrigal Pharmaceuticals, Inc.
Description: Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The company has research, development, and commercialization agreement with Hoffmann-La Roche to develop, use, sell, offer for sale, and import various licensed products.
Industry: Biotechnology
Founded Year : 2011
Headquarter : West Conshohocken, PA, USA
Website: http://www.madrigalpharma.com
Phone: 484-380-9263
[stock_market_widget type=”leaderboard” template=”color-background” color=”purple” assets=”MYOV” api=”yf”]
Myovant Sciences Ltd.
Description: Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women’s health and endocrine diseases. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016.
Industry: Biotechnology
Founded Year : 2016
Headquarter : London, United Kingdom
Website: http://myovant.com
Phone: 44 1295 5950
No comment yet, add your voice below!